Skip to main content
GCTK logo
GCTK
(NASDAQ)
GlucoTrack, Inc.
$0.36-- (--)
Loading... - Market loading

GlucoTrack (GCTK) Company Profile

Complete business overview, executive team, trading details, and corporate information.

GlucoTrack, Inc.
GCTKNasdaq Stock MarketHealthcareMedical Instruments & Supplies

About GlucoTrack

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone201 842 7715
Address
301 Route 17 North, Suite 800 Rutherford, New Jersey 07070 United States

Corporate Identifiers

CIK0001506983
CUSIP45824Q804
ISINUS45824Q8042
EIN98-0668934
SIC3841

Leadership Team & Key Executives

Dr. Paul V. Goode Ph.D.
Chief Executive Officer, President and Director
Avner Gal MBA, MSc.EE
Co-Founder, Chairman Emeritus, Consultant and Member of Scientific and Clinical Advisory Board
David Malka BA
Co-Founder
Vincent Wong
Chief Operations Officer
Dr. Mark Tapsak Ph.D.
Chief Scientific Officer
Drinda Benjamin
Vice President of Marketing